BLU-945

• Target :

  EGFR

• Related Pathways :

  JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Angiogenesis

• Purity :

  0.9916

• Bioactivity :

  BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs) . BLU-945 inhibits EGFR phosphorylation in EGFR L858R/T790M/C797S and EGFR ex19del/T790M/C797S mutant cell lines. BLU-945 can be used in lung cancer research, including non-small cell lung cancer (NSCLC) .

• Smiles :

  CO[C@@H]1CCN(C[C@@H]1F)c1nccc(Nc2cc3c(ccc(N4C[C@H](CS(C)(=O)=O)[C@H]4C)c3cn2)C(C)C)n1

• Molecular Formula :

  C28H37FN6O3S

• Molecular Weight :

  556.7

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2660250-10-0